Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2026-01-01 @ 10:39 AM
Study NCT ID:
NCT05723692
Status:
COMPLETED
Last Update Posted:
2024-02-06
First Post:
2023-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
Sponsor:
AltruBio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-20
First Submit QC Date:
None
Study First Post Date:
2023-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-04
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL